TMFBiologyFool

Brian Orelli

Somewhere between his graduate thesis on BRCA1, a gene that causes hereditary breast cancer, and his postdoctoral fellowship in DNA repair, Brian realized he enjoyed analyzing other people's data more than running his own experiments. Having gotten his first taste of how to analyze stocks from The Motley Fool many years prior, it was only fitting that he came full circle and started writing about biotech, pharmaceutical, and medical device companies for Fool.com. He also covers the health insurance industry to keep from going into binary-event overload. When not writing at The Motley Fool or trade journals like Nature Biotechnology and BioWorld, Brian can be found coaching soccer or hanging out at the beach in his hometown of San Diego.

TMFBiologyFool’s Activity

Tue Jun 28

NL

Boards Post

TMFBiologyFool replied to the Saul's Investing Discussions board. 6:51 PM

Re: What I did Monday (2 days post-Brexit)

Also, there were 200,000 NEW cases of Hep C in the U.S. last year.

Do you have a citation for that?
CDC estimates 30,500 new cases in 2014 [more]

Pro Boards Post

TMFBiologyFool replied to the Pro boards. 6:36 PM

Thu Jun 23

NL

Article

TMFBiologyFool published an article 4:39 PM

Better Buy: Biogen Inc. vs. Celgene Corporation

A battle of the big biotechs.

NL

Article

TMFBiologyFool published an article 2:16 PM

2 Words That Could Bring Down the Entire Prescription Drug Industry

A little-known provision allows the government to end patents on a drug.

Wed Jun 22

NL

Article

TMFBiologyFool published an article 3:32 PM

Why Emergent BioSolutions Inc. Procured a Lower Price Today

A contract with the U.S. government falls short of expectations.

Mon Jun 20

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 8:23 PM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 4:08 PM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 3:55 PM

Thu Jun 16

NL

Article

TMFBiologyFool published an article 5:20 PM

Merck & Co., Inc. Wins This Round of the Immunotherapy Lung-Cancer Battle

There are still a few more rounds to go.

Wed Jun 15

Rule Breakers article.

TMFBiologyFool published an update. 1:37 PM

Tue Jun 14

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 7:10 PM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 7:08 PM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 7:07 PM

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 5:10 PM

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 4:24 PM

NL

Article

TMFBiologyFool published an article 1:35 PM

Why ImmunoGen, Inc. Noted a Lower Price Today

A capital raise could lead to shareholder dilution.

Mon Jun 13

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 7:34 PM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 7:26 PM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 4:11 PM

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 3:30 PM

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 90.72
Player Rank 6948 out of 74855
Score 790.62
Score Change Today -124.26
Accuracy 66.67%
Active Picks 73
Total Picks 215
Best Pick UNH (+254.19)
Worst Pick INCY (-717.70)
Average Score per Pick 3.68
Charms Earned 9
Highest Rated Favorite zzlangerhans
Go to TMFBiologyFool’s CAPS page

Boards Stats & Trivia

Big red star, 1000 posts CAPS All Star SN Explorer 1 Mission Team Member SN Odyssey
Board Posts 1255
Recs Received 1830
People who have rec'd these posts 594
Recs to Posts Ratio (last 30 days) 11.40
Threads Started 136
Threads Started Percentage 10.84 %
Most Frequent Board Buying or Selling a Home
Very First Post Re: How many is enough? (6/6/2001)
Percentage of Posts Rec'd 55.30 %
Show TMFBiologyFool’s 10 Latest Posts